How many insider trades does FilingIQ track for ARMP?

FilingIQ tracks 25 Form 4 insider transactions for ARMP (Armata Pharmaceuticals, Inc.), covering filings from Mar 27, 2020 onwards. 12 of those were filed in the last 90 days.

Are ARMP insiders net buyers or net sellers?

Across the full Form 4 history for ARMP, 6 transactions (24%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ARMP insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ARMP in?

Armata Pharmaceuticals, Inc. (ARMP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $301.81M.

ARMP insider trading

NYSE American Healthcare

Armata Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

24% / 0%

Market cap

$301.81M

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.

Company website: www.armatapharma.com

ARMP insider activity at a glance

FilingIQ has scored 25 insider transactions for ARMP since Mar 27, 2020. The most recent filing in our index is dated Apr 24, 2026.

Across the full history, 6 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ARMP insider trades is 55.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ARMP trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ARMP?: FilingIQ tracks 25 Form 4 insider transactions for ARMP (Armata Pharmaceuticals, Inc.), covering filings from Mar 27, 2020 onwards. 12 of those were filed in the last 90 days.
Are ARMP insiders net buyers or net sellers?: Across the full Form 4 history for ARMP, 6 transactions (24%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ARMP insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ARMP in?: Armata Pharmaceuticals, Inc. (ARMP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $301.81M.

Methodology & sources

Every ARMP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.